Skip to main content
Clinical Trials/NCT04130295
NCT04130295
Completed
Not Applicable

Influence of Wearable Intensive Nerve Stimulation on Spasticity and Function in Persons With Spinal Cord Injury

Shepherd Center, Atlanta GA1 site in 1 country12 target enrollmentOctober 15, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Spinal Cord Injuries
Sponsor
Shepherd Center, Atlanta GA
Enrollment
12
Locations
1
Primary Endpoint
Change in Spasticity
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Spasticity is muscle spasms, bouncing (clonus) or stiffness that can negatively impact the quality of life of people with spinal cord injury (SCI). In people with spinal cord injury, spasticity can limit muscle control of the arms and hands and cause pain, discomfort, and frustration. Transcutaneous electrical stimulation has been shown to reduce spasticity after SCI. However, this type of stimulation's effects during prolonged, at-home use has not been well studied. Additionally, traditional stimulation techniques are often only available in the clinic. Therefore, this study aims to identify if wearable intensive nerve stimulation decreases spasticity in the legs of people with SCI, and if this intervention is usable and desirable to individuals with SCI.

Detailed Description

Involuntary muscle activation, also referred to as spasticity is a common characteristic of spinal cord injuries. It can present as stiffness, clonus, and spasms that can impact a person's ability to perform daily tasks. Over half of individuals with spinal cord injuries that have spasticity report medication alone does not control the spasticity. Because of this clinical research is investigation different ways to manage spasticity. Stretching and vibration have demonstrated the ability to reduce spasticity but only for short periods of time requiring repeated use of the intervention. Additionally, vibration devices are not very practical to implement at home due to their high cost. Due to these factors, a solution that could be used multiple times a day and remains cost effective is needed. Transcutaneous electrical stimulation (TENS) has also demonstrated effectiveness in reducing spasticity after one session but shows greater benefit when it is able to be used for multiple sessions. A wearable intensive nerve stimulator (WINS) device has been shown to be safe for daily wear which makes it a feasible solution to address spasticity at home. Research has not yet looked at the efficacy of using the WINS device for spasticity and this study proposes to begin to fill that gap.

Registry
clinicaltrials.gov
Start Date
October 15, 2019
End Date
March 25, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Shepherd Center, Atlanta GA
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Be 18-65 years of age
  • Have sustained cervical or thoracic SCI at least 6 months prior to initiating participation in study
  • Any ISNCSCI severity classification (A, B, C, or D)
  • Have self-reported spasticity and at the time of screening demonstrate an FSE angle of ≤ 75 degrees on the pendulum test or ≥ 4 beats of clonus on the drop test
  • May participate if utilizing oral prescription medications for control of spasticity
  • Ability and willingness to consent and authorize use of personal health information

Exclusion Criteria

  • Severe contractures of the leg/foot to be stimulated (decided during pre-assessment) that limit passive movement of the hip, knee, or ankle more than 50% of normal range of motion or presence of other orthopedic pathology that would adversely influence participation in the protocol
  • Any implanted catheter such as but not limited to CSF shunt, baclofen pump, or the presence of a pacemaker, implanted automatic internal cardioverter defibrillator (AICD, other cardiac implants and or conditions)
  • Severe pain or hypersensitivity of the leg to be stimulated (decided during pre-assessment)
  • Uncontrolled edema of the leg to be stimulated (decided during pre-assessment)
  • Current pregnancy
  • Lumbar spinal cord injury level
  • Inability or unwillingness to consent and authorize use of personal health information

Outcomes

Primary Outcomes

Change in Spasticity

Time Frame: Week 1, Week 2, Week 3, and Week 7

Instrumented Pendulum Test: Participants will be in a semi-reclined position on a therapy mat. The examiner will then bring the participants knee into full extension before dropping the foot. The examiner will observe the number of oscillations to determine muscle stretch-induced activity

Spinal Cord Injury - Spasticity Evaluation Tool

Time Frame: Twice per week

a Questionnaire used to characterize the impact of spasticity on a participant's ability to perform everyday occupations.

Satisfaction and Adherence Questionnaire

Time Frame: Week 7

Participant will answer questions about how likely they would be to continue to use the intervention at home.

Secondary Outcomes

  • Manual Ankle Clonus Test(Week 1, Week 2, Week 3, and Week 7)
  • Flexor Spasms(Week 1, Week 2, Week 3, and Week 7)
  • Adherence Data(Week 3, Week 4, Week 5, and Week 7)
  • Assessing neurophysiological aspects of spasticity(Week 1, Week 2, Week 3, and Week 7)
  • Instrumented Flexor Reflex Response(Week 1, Week 2, Week 3, and Week 7)
  • Global Impression of Change Scale(Week 1, Week 2, Week 3, and Week 7)
  • Ankle Drop Test(Week 1, Week 2, Week 3, and Week 7)

Study Sites (1)

Loading locations...

Similar Trials